Skip to content
ClinCalc Pro
Menu
Topical analgesic (TRPV1 agonist)

Capsaicin

Brand names: Zacin (0.025%), Axsain (0.075%), Qutenza (8% patch)

Capsaicin is a topical analgesic, derived from chilli peppers, used for neuropathic pain and for symptomatic relief in osteoarthritis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is an agonist at the TRPV1 receptor on sensory nerves, initially stimulating then desensitising nociceptive fibres and depleting substance P, reducing pain transmission.

Prescribing in practice

  • Avoid contact with eyes, mucous membranes and broken or inflamed skin, and ensure hands are washed thoroughly after application to prevent spread.
  • A transient local burning sensation is common on application and usually diminishes with continued use.
  • High-concentration cutaneous patches must be applied by a trained healthcare professional in an appropriate setting.

Monitoring

Monitor the application site for local skin reactions and assess analgesic response over time.

Counselling the patient

  • Apply to intact skin only and wash your hands thoroughly afterwards, or use gloves.
  • Expect a burning or stinging sensation at first, which usually eases with regular use.
  • Do not apply heat such as a hot bath or heat pad to the treated area.

Evidence & guidelines

Topical capsaicin is recommended in clinical guidance as an option for localised neuropathic pain and osteoarthritis.

Reference: SmPC Zacin / Axsain / Qutenza; NICE NG226 (Osteoarthritis 2022); NICE CG173 (Neuropathic Pain 2013); BPS Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.